PE20001342A1 - Compuestos triciclicos como inhibidores de farnesil transferasa - Google Patents

Compuestos triciclicos como inhibidores de farnesil transferasa

Info

Publication number
PE20001342A1
PE20001342A1 PE1999001295A PE00129599A PE20001342A1 PE 20001342 A1 PE20001342 A1 PE 20001342A1 PE 1999001295 A PE1999001295 A PE 1999001295A PE 00129599 A PE00129599 A PE 00129599A PE 20001342 A1 PE20001342 A1 PE 20001342A1
Authority
PE
Peru
Prior art keywords
alkyl
aryl
arylalkyl
tumors
carcinoma
Prior art date
Application number
PE1999001295A
Other languages
English (en)
Spanish (es)
Inventor
Adriano Afonso
Jay Weinstein
Carmen Alvarez
Jianping Chao
Alan B Cooper
Jagdish A Desai
Ronald J Doll
Johan A Ferreira
Viyyoor M Girijavallabhan
Timothy Guzi
Joseph M Kelly
Tarik Lalwani
Alan K Mallams
Dinanath F Rane
Arthur G Taveras
James J-S Wang
Cynthia J Aki
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PE20001342A1 publication Critical patent/PE20001342A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Electroluminescent Light Sources (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PE1999001295A 1998-12-18 1999-12-17 Compuestos triciclicos como inhibidores de farnesil transferasa PE20001342A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21639898A 1998-12-18 1998-12-18

Publications (1)

Publication Number Publication Date
PE20001342A1 true PE20001342A1 (es) 2000-12-09

Family

ID=22806914

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999001295A PE20001342A1 (es) 1998-12-18 1999-12-17 Compuestos triciclicos como inhibidores de farnesil transferasa

Country Status (20)

Country Link
EP (1) EP1140902A1 (enExample)
JP (1) JP2002533336A (enExample)
KR (1) KR20010081116A (enExample)
CN (1) CN1326850C (enExample)
AR (1) AR021718A1 (enExample)
AU (1) AU776558B2 (enExample)
BR (1) BR9916314A (enExample)
CA (1) CA2354779A1 (enExample)
CO (1) CO5160350A1 (enExample)
CZ (1) CZ20011950A3 (enExample)
HU (1) HUP0202152A2 (enExample)
IL (1) IL143408A0 (enExample)
NO (1) NO20012961L (enExample)
NZ (1) NZ511878A (enExample)
PE (1) PE20001342A1 (enExample)
PL (1) PL348293A1 (enExample)
SK (1) SK7592001A3 (enExample)
TR (1) TR200101755T2 (enExample)
WO (1) WO2000037459A1 (enExample)
ZA (1) ZA200104233B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002533336A (ja) 1998-12-18 2002-10-08 シェーリング コーポレイション 三環式ファルネシルタンパク質トランスフェラーゼインヒビター
US7342016B2 (en) 2000-08-30 2008-03-11 Schering Corporation Farnesyl protein transferase inhibitors as antitumor agents
AU2002236813A1 (en) 2001-01-22 2002-07-30 Schering Corporation Treatment of malaria with farnesyl protein transferase inhibitors
WO2002080895A2 (en) * 2001-04-06 2002-10-17 Schering Corporation Treatment of malaria with farsenyl protein transferase inhibitors
CN101115486A (zh) 2004-12-13 2008-01-30 先灵公司 新的法呢基蛋白转移酶抑制剂及其治疗癌症的用途
CN101128202A (zh) 2004-12-14 2008-02-20 先灵公司 法呢基蛋白质转移酶抑制剂和用于治疗增殖性疾病的方法
WO2007084498A1 (en) * 2006-01-19 2007-07-26 Schering Corporation Piperazine derivatives as farnesyl protein transferase inhibitors
US9914726B2 (en) 2014-03-19 2018-03-13 Vps-3, Inc. 2-(2,4-difluorophenyl)-1,1-difluoro-1-(5-substituted-pyridin-2-yl)-3-(1H-tetrazol-1-yl)propan-2-ols and processes for their preparation
CN109678791B (zh) 2014-03-19 2022-07-01 美国陶氏益农公司 1-(2,4-二氟苯)-2,2-二氟-2-(5-取代吡啶-2-基)乙酮及制备方法
JP7751894B2 (ja) * 2021-03-30 2025-10-09 ナミックス株式会社 硬化触媒、樹脂組成物、封止材、接着剤、及び硬化物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
IL117798A (en) * 1995-04-07 2001-11-25 Schering Plough Corp Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them
US5801175A (en) * 1995-04-07 1998-09-01 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
US5712280A (en) 1995-04-07 1998-01-27 Schering Corporation Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases
PE92098A1 (es) * 1996-07-31 1998-12-31 Schering Corp N-cianoiminas triciclicas utiles como inhibidores de transferasa de proteina farnesilo
ATE273299T1 (de) 1997-06-17 2004-08-15 Schering Corp Benzpyrido cycloheptan derivate mit farnesyl protein transferase inhibierender wirkung
JP2002533336A (ja) 1998-12-18 2002-10-08 シェーリング コーポレイション 三環式ファルネシルタンパク質トランスフェラーゼインヒビター

Also Published As

Publication number Publication date
KR20010081116A (ko) 2001-08-27
SK7592001A3 (en) 2002-03-05
CA2354779A1 (en) 2000-06-29
NO20012961D0 (no) 2001-06-15
BR9916314A (pt) 2001-10-02
TR200101755T2 (tr) 2001-09-21
CO5160350A1 (es) 2002-05-30
CN1326850C (zh) 2007-07-18
AU2030700A (en) 2000-07-12
PL348293A1 (en) 2002-05-20
ZA200104233B (en) 2002-08-22
AR021718A1 (es) 2002-07-31
IL143408A0 (en) 2002-04-21
EP1140902A1 (en) 2001-10-10
WO2000037459A1 (en) 2000-06-29
CN1334811A (zh) 2002-02-06
JP2002533336A (ja) 2002-10-08
CZ20011950A3 (cs) 2001-12-12
NO20012961L (no) 2001-08-16
NZ511878A (en) 2003-10-31
HUP0202152A2 (en) 2002-10-28
AU776558B2 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
PE20001516A1 (es) Compuestos triciclicos como inhibidores de la farnesil transferasa
BG104842A (en) New hydroxyindoles, their use as phosphodiesterase 4 inhibitiors and methods for producing same
ES2188016T3 (es) Derivaqdo de benzamidoxima, productos intermedios y procedimiento para su obtencion y su empleo como fungicidas.
ES2132373T3 (es) Benzocicloheptenos, benzoxepinas y benzotiepinas.
JPS5278900A (en) Improvement in organic compound
ATE137805T1 (de) Verfahren zur erhöhung von chemilumineszenz
PT1064281E (pt) Derivados de distamicina benzo-heterociclicos processo para os preparar e a sua utilizacao como agentes antitumorais
ES305661A1 (es) Procedimiento para la produccion de derivados de fenilciclopropano.
KR850003719A (ko) 시아노피라졸 제초제에 대한 개량
PT90912A (pt) Processo para a preparacao de derivados de tiofenol
GB1098806A (en) Novel benzoxazinethiones
PE20020687A1 (es) Imidazoles y tiazoles sustituidos como inhibidores de la farnesil transferasa
ES288448A1 (es) Procedimiento de obtención de nuevos tintes monoazoicos
ES8405003A1 (es) Un procedimiento para la preparacion de un derivado de piridoindol.
GB1477957A (en) Heterocyclic substituted styrenes and their use as optical brighteners
GB1076747A (en) Substituted quinazolones
ES2035919T3 (es) Composiciones fungicidas.
ES369477A1 (es) Procedimiento para la obtencion de compuestos azoicos.
ES438757A1 (es) Un procedimiento de obtencion de las meta-trifluormetilben- cilaminas sustituidas al nitrogeno.
CO5050289A1 (es) Proceso novedoso
ES421091A1 (es) Procedimiento para la preparacion de nuevas 6-azabenzo-1,5-diazepinas.
PE20030197A1 (es) Derivados de pirrol heteroarilo-substituidos como inhibidores de la produccion de citosinas inflamatorias
ES382883A1 (es) Procedimiento para la obtencion de colorantes monoazoicos insolubles en agua.
ES399022A1 (es) Procedimiento para la preparacion de cetonas derivadas de la dihidro-10,11 dibenzo (b,f) azepina.
ES2194361T3 (es) Procedimiento y compuestos intermedios para la preparacion de un herbicida de triazol.

Legal Events

Date Code Title Description
FC Refusal